Last update 08 May 2025

Lutetium-177 DOTA-Zoledronate

Overview

Basic Info

Drug Type
Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals
Synonyms
n.c.a Lutetium-177 DOTA-Zoledronate, n.c.a. 177Lu-DOTA-Zoledronate, n.c.a. 177Lu-Zoledronate
+ [2]
Target
FDPS
Action
inhibitors
Mechanism
FDPS inhibitors(Farnesyl diphosphate synthase inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Bone metastases
Inactive Indication
Osteosarcoma
Originator Organization
Universitätsmedizin der Johannes Gutenberg-Universität MainzUniversitätsmedizin der Johannes Gutenberg-Universität Mainz
Active Organization
Grand Pharmaceutical (China) Co., Ltd.Grand Pharmaceutical (China) Co., Ltd.
Inactive Organization
Itm Isotope Technologies Munich SE
License Organization
Grand Pharmaceutical (China) Co., Ltd.Grand Pharmaceutical (China) Co., Ltd.Itm Isotope Technologies Munich SE
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

100 Clinical Results associated with Lutetium-177 DOTA-Zoledronate
Login to view more data
100 Translational Medicine associated with Lutetium-177 DOTA-Zoledronate
Login to view more data
100 Patents (Medical) associated with Lutetium-177 DOTA-Zoledronate
Login to view more data
100 Deals associated with Lutetium-177 DOTA-Zoledronate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bone metastasesPhase 1
China
Grand Pharmaceutical (China) Co., Ltd.Grand Pharmaceutical (China) Co., Ltd.
10 Aug 2022
OsteosarcomaPhase 1
Germany
Itm Isotope Technologies Munich SE
01 Oct 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free